Iris Bonfitto
Biographic Data
| ID | 7642968 |
|---|---|
| NAME | Iris Bonfitto |
| GIVEN NAMES | Iris |
| FAMILY NAME | Bonfitto |
| SIGNATURE | BONFITTO I |
| AFFILIATIONS | University of Foggia |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics
Background: Severe mental illnesses are associated with increased risks for metabolic syndrome (MetS) and other medical disorders, often with unfavorable outcomes. MetS may be more likely with schizoaffective disorder (SzAff) than schizophrenia (Sz). MetS is associated with long-term antipsychotic drug treatment, but relative risk with orally administered vs. long-acting injected (LAI) antipsychotics is uncertain. Methods: Subjects ( n = 151 with…
No prominent works on this page.
Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics
Background: Severe mental illnesses are associated with increased risks for metabolic syndrome (MetS) and other medical disorders, often with unfavorable outcomes. MetS may be more likely with schizoaffective disorder (SzAff) than schizophrenia (Sz). MetS is associated with long-term antipsychotic drug treatment, but relative risk with orally administered vs. long-acting injected (LAI) antipsychotics is uncertain. Methods: Subjects ( n = 151 with…
Amisulpride (1 work) · Antipsychotic (1 work) · Aripiprazole (1 work) · Clozapine (1 work) · Diabetes Management and Research (1 work) · Diabetes, Cardiovascular Risks, and Lipoproteins (1 work) · Internal Medicine (1 work) · Lurasidone (1 work) · Medicine (1 work) · Metabolic syndrome (1 work)